Policy Activity
On February 25, 2024, Aimed Alliance sent a letter to the Oregon Prescription Drug Affordability Board regarding its current patient…
Aimed Alliance recently submitted letters of support to the Washington and Iowa legislatures urging them to swiftly pass biomarker legislation…
Join Aimed Alliance for a FREE webinar on March 18, 2024 at 11AM ET – 12:00PM ET. Ensuring prescription drug affordability…
On September 29, 2023, the United States District Court for the District of Columbia held that the 2021 NBPP, which…
In recent years, the adoption of alternative funding programs (AFPs) among self-funded employer-sponsored plans has risen rapidly. However, few employers…
This month, the Movement Disorder Policy Coalition (MDPC) released a new policy paper, “Parkinson’s Disease: Improving Treatment While Working Toward…
In 2023, Aimed Alliance engaged in a wide variety of activities to protect and enhance the rights of health care…
On January 22, 2024, Aimed Alliance published two new resources on prescription drug affordability boards (PDABs). These boards, established at…